Keros Therapeutics Inc. logo

Keros Therapeutics Inc.

KROS · United States

kerostx.com

Financials as of FY2025

At a glance
  • Depends onUpstream position: supplies 6 industries, depends on 3
  • ScaleMarket cap is $226.53M, lower than 95% of all stocks globally
  • PositionCurrent ratio is 21.96×, higher than 95% of its Biotechnology peers (median 5.6×)
  • Interpretations12 currently firing — 12